Max Robotics — Global Service Robot Directory + US Certification

About

D. Scott Wright is a pioneering pharmaceutical analyst whose career has centered on advancing bioanalytical sample preparation and chromatographic methods for drug quantification in biological fluids. His foundational work on liquid-solid isolation (LSI) techniques—detailed in his most cited paper (1988, 58 citations)—provided a systematic framework for rapidly developing selective, sensitive assays for drugs and metabolites in complex matrices, bridging manual and robotic approaches. Wright further demonstrated his commitment to automation by designing and validating an automated solid-phase extraction (SPE) method development system (1996, 20 citations), which enabled high-throughput, reproducible sample processing using a Zymate XP robot. His expertise in antibiotic analysis is evident in his comprehensive review of analytical methods for cephalosporins (1987, 14 citations), where he established reversed-phase chromatography as the gold standard. Notably, Wright also developed a sensitive HPLC assay for the cholecystokinin-B antagonist CI-988 (1995, 6 citations), showcasing his ability to tackle challenging neuropharmacological targets. With over 100 cumulative citations, Wright’s contributions have shaped modern bioanalytical workflows, making him a key figure in pharmaceutical method development and automation.